| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/27/2009 | EP2062915A2 Immunoglobulin fractions |
| 05/27/2009 | EP2062590A1 Peptide derived from Hepatitis C virus |
| 05/27/2009 | EP2061879A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains |
| 05/27/2009 | EP2061814A2 Antibodies and immunoconjugates and uses therefor |
| 05/27/2009 | EP2061813A1 Human anti-folate receptor alpha antibodies and antibody fragments for the radioimmunotherapy of ovarian carcinoma |
| 05/27/2009 | EP2061812A1 Method for producing antibodies |
| 05/27/2009 | EP2061811A2 Variable region sequences of il-31 monoclonal antibodies and methods of use |
| 05/27/2009 | EP2061810A2 Methods and compositions for the treatment of antibody mediated neuropathies |
| 05/27/2009 | EP2061808A1 Influenza antibodies, compositions, and related methods |
| 05/27/2009 | EP2061805A1 Recombinant hcv e2 glycoprotein |
| 05/27/2009 | EP2061510A1 Treatment and/or prevention of non-infectious medical conditions using antibody-containing compositions |
| 05/27/2009 | EP1817345B1 Antibodies against tenascin-c |
| 05/27/2009 | EP1711615A4 Engineered templates and their use in single primer amplification |
| 05/27/2009 | EP1343880B1 Expression of xenogenous (human) immunoglobulins in cloned, transgenic bovine |
| 05/27/2009 | EP1337554B1 Novel compounds |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1200476B1 Antitumor antibodies, proteins, and uses thereof |
| 05/27/2009 | EP1156826B1 Product and method for treatment of conditions associated with receptor-desensitization |
| 05/27/2009 | EP1132402B1 Peptide fragments having cell death inhibitory activity |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | EP0939796B1 Uses of oncofetal antigen specific cd4, cd8 cytotoxic and suppressor t cells and interleukin-10 |
| 05/27/2009 | CN101443361A Antibodies binding to the extracellular domain of the receptor tyrosine kinase ALK |
| 05/27/2009 | CN101443360A Binding member for GM-CSF receptor |
| 05/27/2009 | CN101443359A Antibodies to EGFL7 and methods for their use |
| 05/27/2009 | CN101443043A Antibody compositions and methods |
| 05/27/2009 | CN101443040A Methods of treating lupus using CD4 antibodies |
| 05/27/2009 | CN101440131A Antibody variable region of a monoclonal antibody against human tumor necrosis factor alpha and a gene encoding the same |
| 05/27/2009 | CN101440130A Variable regions of heavy chain and light chain of antihuman IL-13R alpha 2 monoclonal antibody |
| 05/27/2009 | CN101440129A Anti-HIV-1 outer membrane jogged protein monoclonal antibody |
| 05/27/2009 | CN100491527C Diagnostic method for cancer characterized in the detection of the deletion of G-CSF exon 3 |
| 05/27/2009 | CN100491398C Method of manufacturing human antibody possessing bioreceptor synergist, antagonist and/or inverse synergist |
| 05/27/2009 | CN100491397C Method and compositions for generating human monoclonal antibodies |
| 05/27/2009 | CN100490895C CD40-binding APC-activating molecules |
| 05/26/2009 | US7538196 Immunoglobulin comprising epitopes for tumor-associated cell-surface antigen and CD-28 for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7538086 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cell proliferative disorders |
| 05/26/2009 | US7538083 Compositions and methods for the potentiation of immune responses against target antigens |
| 05/26/2009 | US7537932 Antibodies that bind purified mammalian FLT3 ligands |
| 05/26/2009 | US7537931 a cancer which expresses epidermal growth factor receptor; blocking ligand activation of a receptor; binding of monoclonal antibody 2C4 to ErbB2; chemotherapeutic agents are 5-fluorouracil leucovorin, levamisole |
| 05/26/2009 | US7537916 Using immortalized cells comprising vector coding cytomegalo viral regulatory sequences to propagate immunoglobulins |
| 05/26/2009 | US7537908 Using concentration of high mobility group 1 (HMG1) protein as evaluative tool in detection of infection and acute respiratory distress syndrome; treating obesity with high mobility group antagonist |
| 05/26/2009 | US7537768 Influenza virus vaccine composition and methods of use |
| 05/26/2009 | US7537763 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 05/26/2009 | US7537762 Human monoclonal antibodies to activin receptor-like kinase-1 |
| 05/26/2009 | US7537760 Monoclonal antibodies recognizing BAG3 protein sequences and their use in diagnostic and therapy of cell death-involving diseases |
| 05/26/2009 | US7537759 Modulating angiogenesis |
| 05/26/2009 | US7537758 Antibodies against a peptide epitope of apolipoprotein B |
| 05/26/2009 | US7537757 Administering an antibody that specifically binds to EMAP(endothelial monocyte-activating polypeptides II) to the subject which needs inhibition of EMAP activity in an amount effective to stimulate vascular growth in cardiac muscle |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2450691C Genes and proteins involved in the biosynthesis of lipopeptides |
| 05/26/2009 | CA2174325C Non-antigenic branched polymer conjugates |
| 05/22/2009 | WO2009064924A1 Compositions and methods for making androstenediones |
| 05/22/2009 | WO2009064854A2 Humanized antibodies against tl1a |
| 05/22/2009 | WO2009064805A1 Compositions and methods for the therapy and diagnosis of influenza |
| 05/22/2009 | WO2009064777A2 Production of fc-fusion polypeptides in eukaryotic algae |
| 05/22/2009 | WO2009064399A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | WO2009064321A2 Biomarker detection |
| 05/22/2009 | WO2009063970A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 05/22/2009 | WO2009063965A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/22/2009 | WO2009063647A1 Antibody production method |
| 05/22/2009 | WO2009063461A1 Methods of treating cancer using anti cd24 antibodies |
| 05/22/2009 | WO2009062703A1 Mycophenolic acid immunogens and antibodies |
| 05/22/2009 | WO2009062690A1 Axl antibodies |
| 05/22/2009 | WO2009062238A1 Epitope for neutralizing antibodies |
| 05/22/2009 | WO2009046313A3 Novel compositions and methods for stimulating erythropoiesis in a mammal |
| 05/22/2009 | WO2009045075A3 A monoclonal antibody specific to human embryonic stem cell, a hybridoma secreting the same and a method for detecting or isolating non-differenced embryonic stem cell |
| 05/22/2009 | WO2009040508A3 Methods of detection and enrichment of prpsc by immunoprecipitation and elisa |
| 05/22/2009 | WO2009035412A8 Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| 05/22/2009 | WO2009035357A3 Immunological tests for the presence of bacteria which make use of antibodies obtained using a specific method |
| 05/22/2009 | WO2009028968A8 Cell marker of melanocyte cell lineage and uses thereof |
| 05/22/2009 | WO2008152446A3 Novel glycosylated peptide target in neoplastic cells |
| 05/22/2009 | WO2008102359A9 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 05/22/2009 | WO2008073161A3 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 05/22/2009 | WO2008067497A9 Enriched antibody for detecting mycobacterial infection, methods of use and diagnostic test employing same |
| 05/22/2009 | WO2008051424A8 Human immune therapies using a cd27 agonist alone or in combination with other immune modulators |
| 05/22/2009 | WO2007030244A3 An ultra-high yield intravenous immune globulin preparation |
| 05/22/2009 | WO2006110593A3 Biological targets for the diagnosis, treatment and prevention of cancer |
| 05/22/2009 | WO2006105479A3 Immunomodulating compositions and methods for use in the treatment of human autoimmune diseases |
| 05/22/2009 | WO2006072954A3 Novel il-6 polynucleotides encoding variant il-6 polypeptides and methods using same |
| 05/22/2009 | CA2719103A1 Biomarker detection |
| 05/22/2009 | CA2706549A1 Monoclonal antibody capable of binding to anexelekto, and use thereof |
| 05/22/2009 | CA2705923A1 Antibodies to lrp6 |
| 05/22/2009 | CA2705555A1 Compositions and methods for the therapy and diagnosis of influenza |
| 05/22/2009 | CA2705542A1 Production of fc-fusion polypeptides in eukaryotic algae |
| 05/22/2009 | CA2705539A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | CA2705509A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 05/22/2009 | CA2705353A1 Methods of treating cancer using anti cd24 antibodies |
| 05/22/2009 | CA2705292A1 Humanized antibodies against tl1a |
| 05/22/2009 | CA2705289A1 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 05/22/2009 | CA2705164A1 Axl antibodies |
| 05/22/2009 | CA2702971A1 Antibody production elicited by a dna vaccine delivered by electroporation |
| 05/22/2009 | CA2701339A1 Mycophenolic acid immunogens and antibodies |
| 05/21/2009 | US20090133135 Diagnostic and Therapeutic Target SLC39A11 Proteins for Neurodegenerative Diseases |
| 05/21/2009 | US20090133134 Method and composition for genetically modifying non-human cells and animals |
| 05/21/2009 | US20090131639 Antibody-containing solution formulations |
| 05/21/2009 | US20090131638 Anti-myostatin antibodies |
| 05/21/2009 | US20090131634 Method for Preparing Cell Fraction Containing Hemangioblasts |
| 05/21/2009 | US20090131524 Sialic acid abc transporters in prokaryotes therapeutic targets |